Samuel Pine is an accomplished scientific leader with over 25 years of experience in the pharmaceutical, vaccine, and diagnostic sectors. Currently serving as the Head of Pharmacology, Toxicology & Bioanalysis at argenx, they have previously held roles including Global Head of Bioanalysis & Immunogenicity at Sanofi and Head of Bioanalysis & Immunogenicity at Ablynx. Samuel has contributed significantly to portfolio milestones, corporate biomarker strategies, and regulatory submissions, while also engaging as a scientific advisor in international working groups. They earned a PhD in Pathobiology from the University of Washington and have held various positions across leading organizations throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices